AveXis

Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

Launch date

2013

Employees

Market cap

Enterprise valuation

Dallas Texas (HQ)

http://avexis.com

https://twitter.com/avexisinc https://www.facebook.com/554499151263809 https://www.linkedin.com/company/avexis-inc-https://apps.apple.com/app/id1454846396

Revenues, earnings & profits over time

EUR	2015	2016	2017
R&D budget	25.0m	56.0m	125m

Source: Dealroom estimates

Date	Investors	Amount	Round
-	Vivo Capital Foresite Capital RA Capital Management PBM Capital Group	N/A	-
Jul 2013	N/A	N/A	Series A
Apr 2014	N/A	N/A	Series B
Jan 2015	Deerfield Roche Venture Fund	$10.0m	Series C
Sep 2015	T. Rowe Price	$65.0m	Series D
Feb 2016	N/A	N/A	IPO
Aug 2017	N/A	N/A	Acquisition
Jan 2019	North Carolina Biotechnology Center	$100k	Grant
Total Funding		$75.1m

Tech stackLearn more about the technologies and tools that this company uses.